Outcomes of transferring embryos identified as abnormal

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the outcomes of pregnancies resulting from the transfer of embryos that have been identified as aneuploid or mosaic through preimplantation genetic testing. It will evaluate the frequency of live births from these embryos and investigate any associated risks for complications during pregnancy and potential health or developmental issues in the children during their first five years. Participants will provide medical records and pediatric data, and the study will meticulously document genetic testing results and pregnancy outcomes. The research is conducted at Stanford University, focusing on patients with no other viable embryo options.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Available aneuploid or mosaic embryos
* No other acceptable embryos available
* Willing to travel to Stanford for treatment
* English language fluency

Exclusion Criteria:

* Use of international donor eggs or sperm not tested according to FDA guidelines.
* Living outside the United States
* Embryos with Triploidy are not eligible for transfer in this protocol

Where it's running

• Stanford Fertility and Reproductive Medicine Center
  Sunnyvale, California, United States Recruiting

Study contacts

• Principal investigator: Ruth Lathi, MD — Stanford University
• Study coordinator: Ronit Mazzoni, MS
• Email: rmazzoni@stanford.edu
• Phone: 408-688-9892

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tracking outcomes after transferring embryos with non-euploid PGT-A results

  This registry collects pregnancy and child health information from people using IVF who plan to transfer embryos with non-euploid PGT-A results to see what the outcomes are.

  Recruiting Inception Fertility Research Institute, LLC · Houston, Texas · NCT07036536

• Long-term outcomes after vacuum-induced tamponade for postpartum hemorrhage

  This study will look at women who had postpartum hemorrhage treated with vacuum-induced tamponade at a Zurich hospital to see how they fared over time, including future pregnancies and fertility.

  Recruiting University of Zurich · Zurich, Canton of Zurich · NCT07885072

• Non-invasive fetal cell test to check fetal chromosomal status in early pregnancy

  A large, non-invasive blood test in pregnant people between 10 and 20 weeks looks for fetal cells in the mother's blood to see if the baby has certain chromosomal conditions, comparing results to invasive or postnatal diagnoses.

  Recruiting at 9 sites BillionToOne Inc. · Phoenix, Arizona and 8 other locations · NCT07643896

• Evaluating embryo testing for chromosomal abnormalities

  This study is testing if a new method of checking embryos for genetic problems can help couples using fertility treatments have healthier babies and reduce the chances of miscarriage.

  Recruiting Aalborg University Hospital · Aalborg · NCT06915311

• Impact of physical activity on fertility and pregnancy outcomes in Danish couples

  This study is testing if getting more physical activity and support can help women trying to conceive have healthier pregnancies and better outcomes.

  Recruiting University of Aarhus · Aarhus · NCT06705712

• Comparing two methods for sperm preparation in IVF

  This study is testing which of two sperm preparation methods helps improve the chances of having healthy embryos for couples undergoing IVF.

  Recruiting The University of Hong Kong · Hong Kong, Hong Kong · NCT06023472

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.